Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
7.28 Up 0.06(0.83%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development12,842  10,107  11,341  16,569  
Selling General and Administrative3,393  3,388  2,734  3,545  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (16,235) (13,495) (14,075) (20,114)
Income from Continuing Operations
Total Other Income/Expenses Net158  153  166  186  
Earnings Before Interest And Taxes(16,077)(13,342)(13,909)(19,928)
Interest Expense11  8  10  12  
Income Before Tax(16,088)(13,350)(13,919)(19,940)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(16,088)(13,350)(13,919)(19,940)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (16,088) (13,350) (13,919) (19,940)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (16,088) (13,350) (13,919) (19,940)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.